Document Details

Form
Filing Date
Jul 6, 2026
Document Date
Jul 1, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Keros Therapeutics
Issuer
Keros Therapeutics, Inc.
Filer
Prener Anne

Investor Contact